LTBI 치료는 활성 TB 환자에 자주 노출되는 환자 및 임상 위험 인자에 대해서만 권장된다.
LTBI treatment is recommended only for patients at risk for progression to active TB―those with frequent exposure to active TB cases, and those with clinical risk factors.